{"title":"反复发作的荨麻疹患者的生活质量及不同治疗方法的效果","authors":"Y. Dytiatkovska, N. Nedohybchenko","doi":"10.29254/2077-4214-2023-2-169-185-196","DOIUrl":null,"url":null,"abstract":"the negative effect of the dis - ease on quality of life also considerably reduced. However, at the end of the observation, the severity of urticaria and all domains of the negative impact of the disease on the quality of life remained pronounced in patients of this group. Treatment with omalizumab at a dosage of 150 mg once every 21 days in this patient category can be considered an effective therapy method that eliminates the symptoms of urticaria and significantly improves the quality of life.","PeriodicalId":9360,"journal":{"name":"Bulletin of Problems Biology and Medicine","volume":"125 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE QUALITY OF LIFE OF PATIENTS WITH FREQUENTLY RECURRING URTICARIA AND THE EFFECT OF DIFFERENT TREATMENT METHODS\",\"authors\":\"Y. Dytiatkovska, N. Nedohybchenko\",\"doi\":\"10.29254/2077-4214-2023-2-169-185-196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"the negative effect of the dis - ease on quality of life also considerably reduced. However, at the end of the observation, the severity of urticaria and all domains of the negative impact of the disease on the quality of life remained pronounced in patients of this group. Treatment with omalizumab at a dosage of 150 mg once every 21 days in this patient category can be considered an effective therapy method that eliminates the symptoms of urticaria and significantly improves the quality of life.\",\"PeriodicalId\":9360,\"journal\":{\"name\":\"Bulletin of Problems Biology and Medicine\",\"volume\":\"125 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of Problems Biology and Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29254/2077-4214-2023-2-169-185-196\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Problems Biology and Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29254/2077-4214-2023-2-169-185-196","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
THE QUALITY OF LIFE OF PATIENTS WITH FREQUENTLY RECURRING URTICARIA AND THE EFFECT OF DIFFERENT TREATMENT METHODS
the negative effect of the dis - ease on quality of life also considerably reduced. However, at the end of the observation, the severity of urticaria and all domains of the negative impact of the disease on the quality of life remained pronounced in patients of this group. Treatment with omalizumab at a dosage of 150 mg once every 21 days in this patient category can be considered an effective therapy method that eliminates the symptoms of urticaria and significantly improves the quality of life.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
